Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Antibiotics (Basel, Switzerland)|July 29, 2023
Characterization of the Antibacterial Activity of Quinone-Based Compounds Originating from the Alnumycin Biosynthetic Gene Cluster of a <i>Streptomyces</i> IsolateLeonie Sagurna, Sascha Heinrich, Lara-Sophie Kaufmann, et al.
Cells|May 16, 2023
Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral TargetJulia Tillmanns, Sigrun Häge, Eva Maria Borst, et al.
The Journal of Biological Chemistry|March 4, 2008
The role of RIP2 in p38 MAPK activation in the stressed heartSebastien Jacquet, Yasuhiro Nishino, Sarawut Kumphune, et al.
The Journal of Biological Chemistry|December 13, 2003
RICK activates a NF-kappaB-dependent anti-human cytomegalovirus responseJan Eickhoff, Miriam Hanke, Matthias Stein-Gerlach, et al.
European Journal of Medicinal Chemistry|December 23, 2023
Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from FlatlandFrithjof Bjørnstad, Simen Havik, Thomas Ihle Aarhus, et al.
European Journal of Medicinal Chemistry|May 4, 2023
A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiationThomas Ihle Aarhus, Jan Eickhoff, Bert Klebl, et al.
Virus Research|August 17, 2023
Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiencyMartin Schütz, Christina Wangen, Mona Sommerer, et al.
Science Immunology|August 26, 2018
Gasdermin D plays a vital role in the generation of neutrophil extracellular trapsGabriel Sollberger, Axel Choidas, Garth Lawrence Burn, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrationsCorina Hutterer, Jan Eickhoff, Jens Milbradt, et al.
Expert Opinion on Drug Discovery|July 12, 2017
Stabilization of protein-protein interactions in drug discoverySebastian A Andrei, Eline Sijbesma, Michael Hann, et al.
Pageof 4